The Oncology PGY-2 residency program at Rush University Medical Center is a one year residency established to provide specialty training for residents interested in hematology, oncology and stem cell transplant. The PGY2 began in 2012 and currently the program has one PGY2 oncology resident. The program has received accreditation by the American Society of Health-System Pharmacists (ASHP). The program is designed to develop the resident’s clinical expertise in the care of hematology/oncology patients through a variety of core and elective rotations. Additionally, residents will have opportunities to gain experience in teaching, research, oncology informatics and quality improvement. Residents who successfully complete our program are prepared for advanced patient care positions, along with board certification in oncology pharmacy.
The resident will be required to participate in a 24-hour onsite, on-call program through the Department of Pharmacy, on average once every 10-14 nights and a commitment to work in the Department of Pharmacy every fourth weekend throughout the year. In addition, there will be several required presentations, a research project, and teaching and precepting opportunities.
The resident is expected to have successfully completed an ASHP-accredited PGY-1 residency. Other requirements include, current curriculum vitae, letter of intent, PharmD from an ACPE-accredited college of pharmacy, eligible for Illinois licensure, 3 letters of recommendation, and pharmacy school transcripts.
About Rush University Medical Center
Rush University Medical Center encompasses a 664-bed hospital serving adults and children, including the Johnston R. Bowman Health Center.
A unique combination of research and patient care has earned Rush national rankings in nine of 16 specialty areas in U.S. News & World Report's 2013-14 America's Best Hospitals issue, among other recognitions of our quality of care and accreditations.
The Department of Pharmacy at Rush consists of over 100 employees working with the latest technology to provide safe and cost-effective care to patients. The practice model is such that it can provide clinical services to patients 24 hours/day, 7 days/week. The residency program has been in place for 35 years and currently consists of 8 PGY1 residents and 6 PGY2 residents (1 of which are supported by Midwestern University's Chicago College of Pharmacy).